Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes
NCT ID: NCT00379652
Last Updated: 2023-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1204 participants
INTERVENTIONAL
2009-10-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Intervention Participation in DASH
NCT04515303
Improving Diabetes Care for African Americans
NCT00436176
Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension
NCT05565716
Improving Diabetes Care Collaboratively in the Community
NCT00359996
Team Lifestyle Immersion Hypertension Control Project
NCT07201948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will develop a collaborative partnership between various health organizations and seven CHCs located in Boston neighborhoods that have a large percentage of African American and Hispanic residents. Researchers will conduct focus groups with CHC patients who are receiving care for hypertension or diabetes. CHC staff members will be interviewed to collect information regarding the relationship between CHC organizational structure and disparities in heart disease risk factors among minority patients with hypertension or diabetes. Researchers will then develop, implement, and evaluate a patient- and CHC-focused intervention aimed at reducing the cardiovascular risks of minority patients at four CHCs in Boston.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Patient-based intervention
Patient Education and Support
The details for the patient education and support intervention will be decided at a later date.
B
Health center-based intervention
Medical Practice Improvement
The details for the medical practice improvement intervention will be decided at a later date.
C
Combination of patient and health center-based intervention
Combination Intervention to Include Medical Practice Improvement and Patient Education and Support
The details for this combination intervention will be decided at a later date.
D
Control group: Neither patient-based nor center-based intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical Practice Improvement
The details for the medical practice improvement intervention will be decided at a later date.
Patient Education and Support
The details for the patient education and support intervention will be decided at a later date.
Combination Intervention to Include Medical Practice Improvement and Patient Education and Support
The details for this combination intervention will be decided at a later date.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypertension, as diagnosed by the average of two or more blood pressure measurements taken during two or more study visits following an initial screening
* Race is 'Black' or ethnicity is 'Hispanic'
* Patient at participating Community Health Center
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Harvard Medical School (HMS and HSDM)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LeRoi S. Hicks, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Harvard Medical School (HMS and HSDM)
Thomas Keegan, PhD
Role: STUDY_DIRECTOR
Harvard Medical School (HMS and HSDM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harvard Medical School
Boston, Massachusetts, United States
Center for Community Health Education, Research, and Service
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ndumele CD, Ableman G, Russell BE, Gurrola E, Hicks LS. Publication of recruitment methods in focus group research of minority populations with chronic disease: a systematic review. J Health Care Poor Underserved. 2011 Feb;22(1):5-23. doi: 10.1353/hpu.2011.0031.
Russell BE, Gurrola E, Ndumele CD, Landon BE, O'Malley JA, Keegan T, Ayanian JZ, Hicks LS; Community Health and Academic Medicine Partnership Project. Perspectives of non-Hispanic Black and Latino patients in Boston's urban community health centers on their experiences with diabetes and hypertension. J Gen Intern Med. 2010 Jun;25(6):504-9. doi: 10.1007/s11606-010-1278-0. Epub 2010 Feb 24.
Ndumele CD, Russell BE, Ayanian JZ, Landon BE, Keegan T, O'Malley AJ, Hicks LS. Strategies to improve chronic disease management in seven metro Boston community health centers. Prog Community Health Partnersh. 2009 Fall;3(3):203-11. doi: 10.1353/cpr.0.0080.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.